Stockscreener 앱 받기
1.21
1.68%
0.02
시간 외 거래:
1.48
0.27
+22.31%
전일 마감가:
$1.19
열려 있는:
$1.1856
하루 거래량:
1.67M
Relative Volume:
0.85
시가총액:
$3.43M
수익:
-
순이익/손실:
$-8.85M
주가수익비율:
-0.0744
EPS:
-16.2673
순현금흐름:
$-9.34M
1주 성능:
-2.42%
1개월 성능:
-37.31%
6개월 성능:
-77.72%
1년 성능:
-90.08%
1일 변동 폭
$1.165
$1.25
1주일 범위
$1.165
$1.26
52주 변동 폭
$1.11
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.21 | 3.37M | 0 | -8.85M | -9.34M | -16.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Dermata Therapeutics (DRMAW) Expected to Announce Earnings on Wednesday - Defense World
Dermata Therapeutics (DRMA) SVP adds 1,000 shares in insider buy - Stock Titan
CEO Change: Whats the outlook for Dermata Therapeutics Incs sectorQuarterly Profit Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Dermata Therapeutics Inc expected to post a loss of $1.54 a shareEarnings Preview - TradingView
Dermata Therapeutics names Kyra Peckaitis VP of marketing By Investing.com - Investing.com Canada
Dermata Therapeutics names Kyra Peckaitis VP of marketing - Investing.com Nigeria
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - lincolnjournal.com
Retail Surge: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and holdJuly 2025 Short Interest & Accurate Intraday Trading Signals - baoquankhu1.vn
Exit Recap: Is Dermata Therapeutics Inc a momentum stockMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Dermata Therapeutics Launches Tome Skincare Line to Address Daily Skin Health Needs - geneonline.com
Dermata Opens a New Chapter with the Release of Tome Skincare - standard-journal.com
Once‑weekly acne treatment at home: Dermata’s new Tome skincare line - Stock Titan
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wall Street Zen Upgrades Dermata Therapeutics (NASDAQ:DRMA) to Hold - Defense World
Dermata Therapeutics Announces Board Resignation and Size Reduction - TipRanks
Board shakeup at Dermata (DRMA) as director Mary Fisher plans exit - Stock Titan
ARMISTICE CAPITAL, LLC Reduces Stake in Dermata Therapeutics Inc - GuruFocus
Update Report: Will Dermata Therapeutics Inc benefit from seasonalityPortfolio Performance Report & Weekly Return Optimization Alerts - baoquankhu1.vn
DRMAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Large Dermata (DRMA) holder Gerald Proehl reports 17.3% ownership stake - Stock Titan
Growth Value: What is Dermata Therapeutics Incs valuation compared to sector2025 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Contrasting Qiagen (NYSE:QGEN) & Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Chipmakers Recap: Can Dermata Therapeutics Inc Equity Warrant grow without external fundingJuly 2025 Rallies & Daily Risk Controlled Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Growth Recap: Is Dermata Therapeutics Inc Equity Warrant benefiting from innovation trendsQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Market Movers | Winners: ADVB, KNRX, DRMA | Losers: MBRX, ALIT, DBGI - Trefis
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Armistice Capital, Steven Boyd disclose 4.99% stake in Dermata (DRMA) - Stock Titan
ACXP PE Ratio & Valuation, Is ACXP Overvalued - Intellectia AI
Can Dermata Therapeutics Inc. expand into new markets2025 AllTime Highs & Verified Technical Trade Signals - mfd.ru
Can Dermata Therapeutics Inc. Equity Warrant stock double in the next yearWeekly Market Summary & AI Powered Market Trend Analysis - mfd.ru
How rising interest rates impact Dermata Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - mfd.ru
HSDT PE Ratio & Valuation, Is HSDT Overvalued - Intellectia AI
DRMA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DRMA Should I Buy - Intellectia AI
Bristol Investment Fund Ltd. v. Dermata Therapeutics Inc.: Complaint (‘$160K Breach of Contract’) - OffshoreAlert
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Will Dermata Therapeutics Inc. stock benefit from AI adoption2025 Momentum Check & AI Forecasted Entry/Exit Points - mfd.ru
Stock Report: Should I average down on Dermata Therapeutics Inc Equity Warrant stockJuly 2025 Short Interest & Real-Time Buy Signal Notifications - baoquankhu1.vn
Surprises Report: What are Twin Hospitality Group Incs technical support levels - baoquankhu1.vn
Is Dermata Therapeutics Inc a momentum stockTrade Volume Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Opening: What are the future prospects of iSpecimen Inc2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Aug Weekly: Is Eureka Acquisition Corp Debt Equity Composite Units a cyclical or defensive stockGold Moves & Fast Moving Trade Plans - baoquankhu1.vn
Will Dermata Therapeutics Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Update & Entry Point Confirmation Signals - mfd.ru
Loss Report: Is Dermata Therapeutics Inc Equity Warrant stock risky to hold nowWeekly Gains Summary & Verified Entry Point Detection - baoquankhu1.vn
History Review: Can ALUR disrupt its industryJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
What is Dermata Therapeutics Inc.’s valuation compared to sectorJuly 2025 Spike Watch & Target Return Focused Picks - mfd.ru
Tuesday's after hours session: top gainers and losers - Chartmill
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):